0001127602-19-027064.txt : 20190820
0001127602-19-027064.hdr.sgml : 20190820
20190820161731
ACCESSION NUMBER: 0001127602-19-027064
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190816
FILED AS OF DATE: 20190820
DATE AS OF CHANGE: 20190820
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Humphries William D.
CENTRAL INDEX KEY: 0001674278
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 191039701
MAIL ADDRESS:
STREET 1: C/O CLEARSIDE BIOMEDICAL, INC.
STREET 2: 1220 OLD ALPHARETTA ROAD, SUITE 300
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bausch Health Companies Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
DATE OF NAME CHANGE: 20100928
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2019-08-16
0000885590
Bausch Health Companies Inc.
BHC
0001674278
Humphries William D.
400 SOMERSET CORPORATE BOULEVARD
BRIDGEWATER
NJ
08807
1
President, Ortho-Dermatologics
Common Stock, No Par Value
2019-08-16
4
P
0
30703
21.1752
A
147721
D
Common Stock, No Par Value
2019-08-16
4
A
0
30703
0
A
178424
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.13 to $21.18 per share. The Reporting Person will provide to the Commission, the Issuer and any stockholder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range provided in this footnote.
Represents matching Restricted Share Units ("MRSUs") granted to the Reporting Person in connection with the open market purchase of Common Shares of the Issuer reported on Table I (the "Purchased Shares"), pursuant to the Issuer's Matching Share Program. One-third of the MRSUs will vest on each of the first, second and third anniversaries following the date of grant ("MRSU Grant Date"), subject to the Reporting Person's continued service (except in limited circumstances).
/s/ Kirsten O'Donnell, attorney-in-fact for William D. Humphries
2019-08-20